Sana Biotechnology to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Company Overview - Sana Biotechnology, Inc. focuses on creating and delivering engineered cells as medicines for patients, aiming to repair and control genes, replace missing or damaged cells, and make therapies broadly available [3]. Upcoming Event - The company will present at the 43rd Annual J.P. Morgan Healthcare Conference on January 15, 2025, at 9:00 a.m. PT, featuring a business overview and update by CEO Steve Harr [1]. - The presentation will be accessible via a webcast on the Investor Relations page of Sana's website, with a replay available for 30 days post-conference [2]. Company Locations - Sana Biotechnology has operations in Seattle, WA; Cambridge, MA; South San Francisco, CA; and Bothell, WA [3].